SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.
Medicine is entering a new era of breakthrough science, with innovations once considered out of reach now becoming reality. Researchers are developing therapies that target diseases in entirely new ...
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...
On July 19th, pioneering medical technology company Xenco Medical unveiled its breakthrough XenVision technology, an AI-powered musculoskeletal intelligence platform that combines advanced computer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results